Stay updated on Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Sign up to get notified when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.

Latest updates to the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page
- Check6 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision entry 'Revision: v3.7.0' has been added to the record history, signaling an updated version of the page. The previous revision 'Revision: v3.6.6' has been removed from the history.SummaryDifference0.1%

- Check48 days agoChange DetectedA new Revision: v3.6.6 appears in the record history, replacing the previous v3.6.5. This update represents a metadata version change to the study record and does not alter the study data or eligibility information.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry (v3.6.5) was added to the record history, indicating an update to the study record since the previous version (v3.6.4). This reflects an internal metadata update rather than a change to study details.SummaryDifference0.1%

- Check83 days agoChange DetectedA new revision entry, v3.6.4, was added to the Record History, representing the latest update to the study record's versioning.SummaryDifference0.1%

- Check105 days agoChange DetectedRecord history shows the latest revision listed as v3.6.3, replacing the prior v3.6.2. This reflects a minor update to the page's release notes rather than substantive changes to study content.SummaryDifference0.1%

Stay in the know with updates to Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.